4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-020708
Director sold 8,100 shares at $7.20 ($58,311)
- Director acquired 27,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stuglik Brian M Director | 2026-06-11 | Grant or award 10b5-1 | +27,000 | 121,958 | D | ||
| Stuglik Brian M Director | 2026-06-12 | Sale 10b5-1 | −8,100 | $7.20 | $58,311 | 113,858 | D |
| Open-market sales · 8,100 sh · avg $7.20 · $58,311 | |||||||
Loading xslF345X06/rdgdoc.xml…